Key statistics
As of last trade Lineage Cell Therapeutics Inc (LCTX:TLV) traded at 331.00, 9.13% above its 52-week low of 303.30, set on Aug 15, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 340.20 |
---|---|
High | 350.50 |
Low | 325.50 |
Bid | 328.00 |
Offer | 330.50 |
Previous close | 325.50 |
Average volume | 4.61k |
---|---|
Shares outstanding | 188.84m |
Free float | 188.00m |
P/E (TTM) | -- |
Market cap | 164.02m USD |
EPS (TTM) | -0.1342 USD |
Data delayed at least 20 minutes, as of Oct 09 2024 07:59 BST.
More ▼
Press releases
- OpRegen® (RG6501) Phase 1/2a Results to Be Featured at International Society for Stem Cell Research (ISSCR) 2024 Copenhagen International Symposium
- Lineage Presents Preclinical Data on Its Auditory Neuronal Cell Transplant Program, ReSonance™, at the 59th Annual Inner Ear Biology Workshop
- Lineage Cell Therapeutics to Present at the H.C. Wainwright 4th Annual Ophthalmology Virtual Conference
- Lineage Cell Therapeutics Reports Second Quarter 2024 Financial Results and Provides Business Update
- Lineage Cell Therapeutics to Report Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024
More ▼